Fri Sep 20 08:08:45 UTC 2024: ## Institutional Investors Adjust Aflac Holdings Amidst Strong Earnings
**New York, NY** – Aflac Incorporated (NYSE: AFL) has seen a flurry of activity from institutional investors in recent months, with some trimming their positions while others are increasing their stakes.
Moors & Cabot Inc., for example, reduced its ownership in the financial services provider by 5.2% during the second quarter, selling 395 shares. However, other investors, such as Norges Bank, Strategic Financial Concepts LLC, and Swedbank AB, have acquired new positions in Aflac, indicating a continued positive outlook for the company.
Aflac recently reported strong second-quarter earnings, exceeding analysts’ expectations. The company earned $1.83 per share, beating the consensus estimate of $1.60, while revenue came in at $5.14 billion, surpassing the projected $4.10 billion. These results further bolster the company’s performance and have likely contributed to the interest from institutional investors.
While some investors remain cautious, exemplified by Barclays’ “underweight” rating, others are bullish on Aflac’s prospects. Piper Sandler, for instance, raised its price target on the stock to $100.00 and issued an “overweight” rating.
Overall, analysts have a mixed view on Aflac, with three rating it a “sell”, nine assigning a “hold”, and three recommending a “buy”. The average target price currently stands at $92.50.
Aflac, through its subsidiaries, provides supplemental health and life insurance products in Japan and the United States. The company is known for its innovative products and strong financial performance.
The recent flurry of activity from institutional investors underscores the market’s continued interest in Aflac, as it navigates its growth trajectory.
First Piper 